ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

ClinicalTrials.gov ID: NCT06136559

Public ClinicalTrials.gov record NCT06136559. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 2:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in Participants With Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011)

Study identification

NCT ID
NCT06136559
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
1,200 participants

Conditions and interventions

Interventions

  • Acalabrutinib Drug
  • Ibrutinib Drug
  • Nemtabrutinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 12, 2023
Primary completion
Sep 6, 2032
Completion
Sep 6, 2032
Last update posted
Apr 27, 2026

2023 – 2032

United States locations

U.S. sites
41
U.S. states
22
U.S. cities
39
Facility City State ZIP Site status
USA Mitchell Cancer Institute ( Site 0014) Mobile Alabama 36604 Recruiting
Banner MD Anderson Cancer Center ( Site 0059) Gilbert Arizona 85234 Recruiting
Banner MD Anderson Cancer Center - University Medical Center Phoenix ( Site 0051) Phoenix Arizona 85006 Recruiting
Arizona Oncology Associates - NAHOA ( Site 8007) Prescott Arizona 86301 Completed
Alta Bates Summit Medical Center ( Site 0004) Berkeley California 94704 Recruiting
Moores Cancer Center ( Site 0003) La Jolla California 92093-0698 Recruiting
Care Access - South Pasadena ( Site 0070) Pasadena California 91105 Recruiting
Saint Joseph Hospital ( Site 0026) Denver Colorado 80218 Recruiting
Lutheran Medical Center ( Site 0027) Golden Colorado 80401 Recruiting
Intermountain Health St. Mary's Regional Hospital ( Site 0025) Grand Junction Colorado 81501 Recruiting
Eastern CT Hematology & Oncology Associates ( Site 0033) Norwich Connecticut 06360 Recruiting
Clermont Oncology Center ( Site 0046) Clermont Florida 34711 Recruiting
Florida Cancer Specialists - South ( Site 7001) Fort Myers Florida 33901 Recruiting
Florida Cancer Specialists - East ( Site 7002) West Palm Beach Florida 33401 Recruiting
Parkview Research Center at Parkview Regional Medical Center ( Site 0002) Fort Wayne Indiana 46845 Recruiting
University of Iowa Health Care. ( Site 0017) Waukee Iowa 50263 Recruiting
University of Iowa Health Care. ( Site 0057) Waukee Iowa 50263 Recruiting
Saint Elizabeth Healthcare ( Site 0041) Edgewood Kentucky 41017 Recruiting
Corewell Health-Lemmon Holton Cancer Pavilion ( Site 0011) Grand Rapids Michigan 49503 Recruiting
Regions Hospital ( Site 0042) Saint Louis Park Minnesota 55416 Recruiting
MidAmerica Cancer Care, LLC ( Site 0043) Kansas City Missouri 64132 Recruiting
Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 0052) Billings Montana 59102 Recruiting
Summit Medical Group Cancer Center ( Site 0007) Florham Park New Jersey 07932 Completed
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0016) Hackensack New Jersey 07601 Recruiting
Roswell Park Cancer Institute ( Site 0023) Buffalo New York 14263 Recruiting
Carolina Oncology Specialists, PA ( Site 0054) Charlotte North Carolina 28207 Recruiting
Southeastern Medical Oncology Center ( Site 0049) Goldsboro North Carolina 27534 Recruiting
Consultants in Medical Oncology and Hematology (CMOH) ( Site 8002) Broomall Pennsylvania 19008 Recruiting
Cancer Care Associates Of York ( Site 0005) York Pennsylvania 17403 Recruiting
Tennessee Oncology-Chattanooga ( Site 0045) Chattanooga Tennessee 37404 Recruiting
Tennessee Oncology, PLLC - Elliston Place Plaza Medical Oncology & Hematology ( Site 0031) Nashville Tennessee 37203 Recruiting
Texas Oncology - Central/South Texas ( Site 8008) Austin Texas 78705 Recruiting
The Center for Cancer and Blood Disorders ( Site 0032) Fort Worth Texas 76104 Recruiting
Texas Oncology - San Antonio ( Site 8006) San Antonio Texas 78217 Recruiting
Texas Oncology - Northeast Texas ( Site 8012) Tyler Texas 75702 Recruiting
University of Virginia Cancer Center ( Site 0040) Charlottesville Virginia 22903 Recruiting
Inova Schar Cancer Institute ( Site 0015) Fairfax Virginia 22031 Recruiting
Virginia Commonwealth University (VCU) Medical Center ( Site 0030) Richmond Virginia 23298 Recruiting
Medical Oncology Associates, PS (dba Summit Cancer Centers) ( Site 0010) Spokane Washington 99208 Recruiting
SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical ( Site 0048) Madison Wisconsin 53715 Recruiting
University Hospital and UW Health Clinics ( Site 0006) Madison Wisconsin 53792 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 155 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06136559, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 27, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06136559 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →